Market Analysis

BIO Ventures for Global Health Study identifies market for tuberculosis vaccines

Published in Vaccine Weekly, November 22nd, 2006

According to a groundbreaking study released by BIO Ventures for Global Health (BVGH), a vaccine to prevent tuberculosis presents a significant opportunity for industry investment with a potential global market of US$450 million to nearly $1 billion.

The first study of its kind, Tuberculosis Vaccines: The Case for Investment analyzes the demand for a tuberculosis vaccine and the potential return on industry investment, while demonstrating that a new TB vaccine would have tremendous public health impact.

"This study supports - with quantitative analysis - the premise that products that address a key problem of global health can also generate...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2006-11-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry